Guohui Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0002-9112-4142

发表论文 82 篇 · 总被引 545 次 · h-index 12

代表论文

• The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment (2022 · Frontiers in Cardiovascular Medicine · 被引 58)
• Split application of a mixture of controlled‐release and common urea for improving quality and agronomic and economic performance in wheat production (2021 · Crop Science · 被引 21)
• The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy (2023 · Frontiers in Oncology · 被引 14)
• Efficacy and safety of first-line treatments with immune checkpoint inhibitors plus chemotherapy for non-squamous non-small cell lung cancer: a meta-analysis and indirect comparison (2021 · Annals of Palliative Medicine · 被引 13)
• Clinicopathological characteristics and prediction of cancer-specific survival in large cell lung cancer: a population-based study (2020 · Journal of Thoracic Disease · 被引 13)
• Cost-effectiveness of pembrolizumab versus docetaxel as second-line treatment of non-small cell lung cancer in China (2021 · Annals of Translational Medicine · 被引 12)